생명과학 툴, 시약 및 코로나19 진단 제품 시장 규모는 2023년 147억 달러, 2024년 130억 달러에서 예측 기간 동안 연평균 3.4% 성장하여 2029년 말에는 154억 달러 규모에 이를 것으로 예상됩니다.
생명과학 툴 및 시약 부문은 2024년 125억 달러에서 연평균 4.2% 성장하여 2029년 말에는 153억 달러에 달할 것으로 예상됩니다. 또한 생명과학의 코로나19 진단 제품 부문은 2024년 4억 7,960만 달러에서 연평균 42.8% 성장하여 2029년 말에는 2,940만 달러에 달할 것으로 예측됩니다.
유럽의 생명과학 툴 및 시약 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 시장 역학
- 세계 시장 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
제4장 신기술과 개발
- 개요
- 차세대 치료제
- 차세대 진단약
- 디지털화
- AI 및 머신러닝
- IoT
- 생명과학 실험실 로봇
제5장 시장 세분화 분석
- 개요
- 세분화 내역
- 유럽의 생명과학 툴 및 시약 시장 : 제품 유형별
- COVID-19 진단 검사 시장
- 생명과학 툴 및 시약 시장
- 유럽의 생명과학 툴 및 시약 시장 : 용도별
- 유전체학
- 단백질체학
- 세포생물학/항체/조합 단백질
- 줄기세포 연구
- 이미징 툴 및 기술
- 동물 모델
- 후성유전학
- 대사체학
- 기타
- 유럽
- 영국
- 독일
- 프랑스
- 스위스
- 스페인
- 이탈리아
- 기타
제6장 경쟁 정보
- PCR 기술과 시약
- 항체
- ELISA 기기
- ELISA 키트 및 어세이
- 생명과학 키트 및 어세이
- COVID-19 진단
- 전략적 이니셔티브
- 시장에서의 최근 제품 도입
제7장 유럽 생명과학 툴 및 시약 시장에서의 지속가능성 : ESG 관점
- ESG : 서론
- 업계의 ESG 실천
- 업계의 ESG 현황
- BCC의 결론
제8장 부록
- 조사 방법
- 두자어
- 출전
- 기업 개요
- AGILENT TECHNOLOGIES INC.
- ALTONA DIAGNOSTICS GMBH
- ANALYTIK JENA GMBH+CO. KG
- BD
- BIO-RAD LABORATORIES INC.
- DANAHER CORP.
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGAA
- PROMEGA CORP.
- QIAGEN
- REVVITY INC.
- THERMO FISHER SCIENTIFIC INC.
LSH
The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.
The European market for life science tools and reagents is expected to grow from $12.5 billion in 2024 to $15.3 billion by the end of 2029, at a CAGR of 4.2% from 2024 through 2029.
The European market for life science COVID-19 diagnostics products is expected to decline from $479.6 million in 2024 to $29.4 million by the end of 2029, at a negative CAGR of 42.8% from 2024 through 2029.
Report Scope
This report provides a comprehensive analysis of the European market for life science tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape, trends and market dynamics, such as drivers, restraints and opportunities. It also analyzes the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science tools included are hybridization systems, PCR, Western blotting instruments and ELISA instruments. The countries whose markets are analyzed are Germany, France, the U.K., Italy, Spain, Switzerland and the Rest of Europe. Markets are also analyzed by application.
Report Includes
- 33 data tables and 54 additional tables
- An analysis of the European market for life science tools and reagents, including COVID-19 diagnostics products
- Analyses of the market trends, with historic market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue forecasts for the market for life science tools and reagents, with market share analysis by product, application, and country
- Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
- Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
- Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
- Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Merck KGaA, Qiagen and Roche
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Product Development in Life Science
Chapter 3 Market Dynamics
- Global Market Dynamics
- Market Drivers
- Increasing Investments in R&D
- Increasing Prevalence of Chronic Diseases
- Increasing Demand for Various Diagnostics Pathways and In Vitro Diagnostics
- Growth in Genomic and Biomarker Research
- Increasing Demand for Personalized Medicine
- Technological Advances
- Market Restraints
- End of COVID-19 Pandemic
- High Cost of Instruments
- Lack of Skilled Personnels
- Market Challenges
- Regulatory Hurdles
- Market Opportunities
- Positive Impact from Some Revisions in Pharmaceutical Legislation
- New Technologies
Chapter 4 Emerging Technologies and Developments
- Overview
- Next-Generation Therapeutics
- Next-Generation Diagnostics
- Digitalization
- AI and Machine Learning
- Internet of Things (IoT)
- Robots in Life Science Labs
Chapter 5 Market Segmentation Analysis
- Overview
- Segmentation Breakdown
- European Market for Life Science Tools and Diagnostics, by Product Type
- COVID-19 Diagnostic Tests Market
- Market for Life Science Tools and Reagents
- European Market for Life Science Tools and Diagnostics, by Application
- Genomics
- Proteomics
- Cell Biology, Antibodies and Recombinant Proteins
- Stem Cells Research
- Imaging Tools and Techniques
- Animal Models
- Epigenetics
- Metabolomics
- Other Applications
- Europe
- United Kingdom
- Germany
- France
- Switzerland
- Spain
- Italy
- Rest of Europe
Chapter 6 Competitive Intelligence
- PCR Technologies and Reagents
- Antibodies
- ELISA Instruments
- ELISA Kits and Assays
- Life Science Kits and Assays
- COVID-19 Diagnostics
- Strategic Initiatives
- Recent Product Introductions in the Market
Chapter 7 Sustainability in Life Science Tools and Reagents in the European Market: An ESG Perspective
- Introduction to ESG
- ESG Practices in the Industry
- Status of ESG in the Industry
- Concluding Remarks from BCC
Chapter 8 Appendix
- Methodology
- Acronyms
- Sources
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- ALTONA DIAGNOSTICS GMBH
- ANALYTIK JENA GMBH+CO. KG
- BD
- BIO-RAD LABORATORIES INC.
- DANAHER CORP.
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGAA
- PROMEGA CORP.
- QIAGEN
- REVVITY INC.
- THERMO FISHER SCIENTIFIC INC.
